Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREFIPS: Somatostatin vs octreotide to prevent postoperative pancreatic fistula
2016-001673-32Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2016
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial in Postoperative pancreatic fistula (POPF) and Pancreatic surgery complications comparing Perioperative somatostatin with Perioperative octreotide (2 arms). Primary endpoint: Clinically relevant postoperative pancreatic fistula (grade B or C). Started Oct 2016; status: completed.
02
Drugs
somatostatinoctreotide
03
Conditions
Postoperative pancreatic fistula (POPF)Pancreatic surgery complications
Beyond the preview
Go deeper on 2016-001673-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001673-32.